J Laiseca García, L Gónzalez Bravo, E Gomez de la Fuente, B Tristán Martin, C Sarró Fuentes, A Rosado
{"title":"盐依赖性水源性荨麻疹，激射试验和组织学特征:病例报告。","authors":"J Laiseca García, L Gónzalez Bravo, E Gomez de la Fuente, B Tristán Martin, C Sarró Fuentes, A Rosado","doi":"10.18176/jiaci.0735","DOIUrl":null,"url":null,"abstract":"J Investig Allergol Clin Immunol 2022; Vol. 32(3): 224-240 © 2022 Esmon Publicidad 8. Guillén D, Bobolea I, Calderon O, Fiandor A, Cabañas R, Heredia R, et al. Aspirin desensitization achieved after omalizumab treatment in a patient with aspirin-exacerbated urticaria and respiratory disease. J Investig Allergol Clin Immunol. 2015;25(2):133-5. 9. Namazy JA, Blais L, Andrews EB, Scheuerle AE, Cabana MD, Thorp JM, et al. Pregnancy outcomes in the omalizumab pregnancy registry and a disease-matched comparator cohort. J Allergy Clin Immunol. 2020 Feb 1;145(2):528-36.e1. 10. Breslow RG, Caiado J, Castells MC. Acetylsalicylic acid and montelukast block mast cell mediator-related symptoms during rapid desensitization. Ann Allergy Asthma Immunol. 2009;102(2):155-60.","PeriodicalId":520676,"journal":{"name":"Journal of investigational allergology & clinical immunology","volume":" ","pages":"230-231"},"PeriodicalIF":4.8000,"publicationDate":"2022-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Salt-Dependent Aquagenic Urticaria, Challenge Test, and Histological Features: Case Report.\",\"authors\":\"J Laiseca García, L Gónzalez Bravo, E Gomez de la Fuente, B Tristán Martin, C Sarró Fuentes, A Rosado\",\"doi\":\"10.18176/jiaci.0735\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"J Investig Allergol Clin Immunol 2022; Vol. 32(3): 224-240 © 2022 Esmon Publicidad 8. Guillén D, Bobolea I, Calderon O, Fiandor A, Cabañas R, Heredia R, et al. Aspirin desensitization achieved after omalizumab treatment in a patient with aspirin-exacerbated urticaria and respiratory disease. J Investig Allergol Clin Immunol. 2015;25(2):133-5. 9. Namazy JA, Blais L, Andrews EB, Scheuerle AE, Cabana MD, Thorp JM, et al. Pregnancy outcomes in the omalizumab pregnancy registry and a disease-matched comparator cohort. J Allergy Clin Immunol. 2020 Feb 1;145(2):528-36.e1. 10. Breslow RG, Caiado J, Castells MC. Acetylsalicylic acid and montelukast block mast cell mediator-related symptoms during rapid desensitization. Ann Allergy Asthma Immunol. 2009;102(2):155-60.\",\"PeriodicalId\":520676,\"journal\":{\"name\":\"Journal of investigational allergology & clinical immunology\",\"volume\":\" \",\"pages\":\"230-231\"},\"PeriodicalIF\":4.8000,\"publicationDate\":\"2022-06-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of investigational allergology & clinical immunology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.18176/jiaci.0735\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2021/9/7 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of investigational allergology & clinical immunology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.18176/jiaci.0735","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/9/7 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Salt-Dependent Aquagenic Urticaria, Challenge Test, and Histological Features: Case Report.
J Investig Allergol Clin Immunol 2022; Vol. 32(3): 224-240 © 2022 Esmon Publicidad 8. Guillén D, Bobolea I, Calderon O, Fiandor A, Cabañas R, Heredia R, et al. Aspirin desensitization achieved after omalizumab treatment in a patient with aspirin-exacerbated urticaria and respiratory disease. J Investig Allergol Clin Immunol. 2015;25(2):133-5. 9. Namazy JA, Blais L, Andrews EB, Scheuerle AE, Cabana MD, Thorp JM, et al. Pregnancy outcomes in the omalizumab pregnancy registry and a disease-matched comparator cohort. J Allergy Clin Immunol. 2020 Feb 1;145(2):528-36.e1. 10. Breslow RG, Caiado J, Castells MC. Acetylsalicylic acid and montelukast block mast cell mediator-related symptoms during rapid desensitization. Ann Allergy Asthma Immunol. 2009;102(2):155-60.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
